Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent
D. R. Session
, K. R. Kalli
, I. S. Tummon
, M. A. Damario
, D. A. Dumesic
Obstetrics, Gynecology and Women's Health - Reproductive Endocrinology and Infertility
Research output
:
Contribution to journal
›
Article
›
peer-review
61
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Endometrial Hyperplasia
100%
Insulin Sensitizers
100%
Progestogens
33%
Diabetes
16%
Endometrial Cancer
16%
Older Patients
16%
Endometrium
16%
Drug Class
16%
Hyperinsulinemia
16%
Endometrial Biopsy
16%
Treatment Initiation
16%
Treatment Failure
16%
Mitogenic Effect
16%
Proliferative Endometrium
16%
Metformin Therapy
16%
Medicine and Dentistry
Endometrial Hyperplasia
100%
Insulin Sensitizing Agent
100%
Endometrium
40%
Gestagen
40%
Diabetes
20%
Glycon
20%
Hyperplasia
20%
Hyperinsulinemia
20%
Endometrial Biopsy
20%
Uterine Cancer
20%